0001127602-11-019972.txt : 20110628
0001127602-11-019972.hdr.sgml : 20110628
20110628172003
ACCESSION NUMBER: 0001127602-11-019972
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110627
FILED AS OF DATE: 20110628
DATE AS OF CHANGE: 20110628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEE KENNETH B JR
CENTRAL INDEX KEY: 0001208570
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 11936567
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
BUSINESS PHONE: 2054444600
MAIL ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
4
1
form4.xml
PRIMARY DOCUMENT
X0303
4
2011-06-27
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001208570
LEE KENNETH B JR
4505 EMPEROR BLVD., SUITE 200
DURHAM
NC
27703
1
Non-Qualified Stock Option
3.80
2011-06-27
4
A
0
22917
0
A
2011-06-30
2021-06-27
Common Stock
22917
22917
D
Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan (the "Plan").
The option vests 1/12 per month for a period of 12 months, beginning on June 30, 2011.
/s/ Kenneth Lee
2011-06-28